Artificial Intelligence (AI) in the NHS: Promise, Progress and the Future of Healthcare

Artificial intelligence (AI) is no longer a futuristic idea within the NHS. AI technologies are already being used in some areas of healthcare across the UK, particularly in radiology, diagnostics, administration and workflow support. However, the reality is more nuanced than many headlines suggest.
At present, AI in the NHS is best understood as a collection of promising technologies being introduced gradually, cautiously and under clinical oversight. Some NHS trusts are using several AI-assisted systems routinely, while others have little or no operational AI deployment beyond pilot projects.
The direction of travel is clear: AI is likely to become an increasingly important part of healthcare over the next decade. However, the NHS is moving carefully because healthcare is a high-risk environment where mistakes can have serious consequences.
What Does AI Mean in Healthcare?
In healthcare, AI usually refers to computer systems that can analyse large amounts of data and identify patterns more quickly or consistently than humans alone.
Examples include:
- Analysing medical scans
- Helping detect cancers or fractures
- Supporting diagnosis
- Summarising clinic consultations
- Reducing paperwork
- Predicting patient deterioration
- Helping prioritise urgent cases
- Supporting medication safety checks
Importantly, most NHS AI systems are currently designed to support clinicians rather than replace them.
AI in NHS Radiology
Radiology is currently one of the biggest areas of AI development within the NHS.
AI systems are being used or trialled to help analyse:
- Chest X-rays
- CT scans
- MRI scans
- Mammograms
- Retinal photographs
- Dermatology images
AI is particularly attractive in radiology because the NHS faces:
- Large radiologist shortages
- Increasing imaging demand
- Growing reporting backlogs
- Rising complexity of scans
How AI Is Currently Used
Most NHS radiology AI systems currently operate in one of three ways:
1. AI as a “Second Reader”
The scan is interpreted by a radiologist, while AI acts as an additional safety check.
AI may flag:
- Possible lung nodules
- Fractures
- Brain bleeds
- Abnormal mammograms
- Signs of stroke
The human clinician still makes the final decision.
2. Prioritisation (“Triage”)
AI can rapidly review scans and move potentially urgent cases higher in the reporting queue.
This may help speed up treatment for:
- Stroke
- Pulmonary embolism
- Pneumothorax (collapsed lung)
- Intracranial bleeding
3. Identifying Likely Normal Scans
Some AI systems are being studied to identify scans that appear very likely to be normal.
The aim is to allow radiologists to focus more attention on:
- Abnormal scans
- Complex cases
- Uncertain findings
However, this remains an area of careful evaluation and regulation.
Does AI Sometimes Perform Better Than Humans?
In certain narrow and repetitive tasks, AI can sometimes outperform humans or help reduce specific types of errors.
AI can be very good at:
- Detecting tiny abnormalities
- Maintaining consistency
- Working without fatigue
- Rapid image analysis
- Comparing huge numbers of images
Humans can become:
- Tired
- Distracted
- Overloaded
- Inconsistent under pressure
For example, AI may detect very small lung nodules or subtle fractures that could potentially be overlooked during a busy reporting session.
However, AI also has important weaknesses.
AI may struggle with:
- Rare diseases
- Complex clinical context
- Unusual anatomy
- Poor-quality scans
- Unexpected combinations of disease
Importantly, AI and humans often make different kinds of mistakes.
The emerging evidence suggests that:
Human + AI is often better than either alone.
Will Radiologists Be Replaced?
At present, the NHS does not view AI as a replacement for radiologists.
Instead, AI is mainly being introduced as:
- A support tool
- A safety net
- A prioritisation system
- A workflow assistant
Radiologists still provide:
- Clinical judgement
- Contextual interpretation
- Decision-making
- Communication
- Management of uncertainty
In the foreseeable future, radiology is likely to become increasingly AI-assisted but still human-led.
Longitudinal Analysis: One of the Most Exciting Future Possibilities
One of the most promising future applications of AI is longitudinal analysis.
This means comparing:
- Current scans
- Previous scans
- Blood tests
- Lung function
- Medications
- Clinical notes
- Symptoms
- Outcomes over time
Humans are not particularly good at consistently recognising very subtle changes across years of imaging and clinical data.
AI could potentially become extremely powerful at:
- Tracking disease progression
- Measuring tumour growth
- Monitoring fibrosis
- Quantifying cavity enlargement
- Identifying treatment response
- Predicting future deterioration
This could be especially valuable in chronic diseases such as:
- Chronic Pulmonary Aspergillosis (CPA)
- Bronchiectasis
- Chronic Obstructive Pulmonary Disease (COPD)
- Interstitial lung disease
- Cancer
In the future, AI may help move medicine from:
“What does this scan show today?”
towards:
“What is happening over time, and what is likely to happen next?”
AI Beyond Radiology
AI Clinical Documentation
The NHS is increasingly exploring AI systems that can generate:
- Clinic letters
- Consultation summaries
- Medical notes
- Coding suggestions
These “AI scribes” may help reduce administrative burden and allow clinicians to spend more time with patients.
AI Triage Systems
Some NHS services now use AI-assisted triage systems to:
- Route patient requests
- Identify urgent problems
- Prioritise appointments
- Support NHS App workflows
Medication Safety
AI may eventually help identify:
- Drug interactions
- Prescribing errors
- Missed monitoring
- Unsafe medication combinations
Operational Efficiency
The NHS is also exploring AI for:
- Appointment scheduling
- Referral management
- Staff rostering
- Reducing missed appointments
- Managing workflow
Why AI Adoption Is Uneven Across the NHS
AI adoption currently varies considerably across the NHS.
Some trusts use multiple AI systems routinely, while others have minimal deployment.
This variation is influenced by:
- Funding differences
- IT infrastructure
- Digital maturity
- Research partnerships
- Clinical confidence
- Procurement complexity
- Availability of evidence
Large teaching hospitals and academic centres often adopt new technologies earlier than smaller hospitals.
As a result, current NHS AI deployment is best described as:
Selective, cautious and evolving.
Why the NHS Is Proceeding Carefully
The NHS is naturally cautious about AI because healthcare is fundamentally different from many other industries.
Mistakes can have serious consequences, including:
- Missed cancers
- Delayed diagnosis
- Medication harm
- Unsafe treatment decisions
For this reason, NHS AI systems generally require:
- Clinical validation
- Governance review
- Safety monitoring
- Regulatory approval
- Human oversight
- Ongoing audit
There is also awareness that:
- commercial hype can exceed evidence,
- real-world NHS workflows are complex,
- and some AI systems may not perform as well outside carefully controlled studies.
Potential Risks and Concerns
Although AI has enormous potential, there are also important concerns.
Patient Safety
AI systems can make mistakes and may occasionally be confidently wrong.
Bias
If training data is incomplete or biased, AI performance may vary between different patient groups.
Loss of Human Contact
Some patients worry that healthcare could become less personal if technology replaces human interaction.
Data Privacy
AI systems often require access to large healthcare datasets, raising understandable questions about confidentiality and data governance.
The Likely Future
The most likely future is probably not:
“AI replaces doctors.”
Instead, it is more likely to be:
“Clinicians increasingly work alongside AI systems.”
AI may gradually become another routine layer of healthcare infrastructure, much as:
- electronic patient records,
- CT scanners,
- MRI scanners,
- and digital pathology systems
became normal parts of modern medicine.
Over time, patients may benefit from:
- Earlier diagnosis
- Safer systems
- More personalised medicine
- Faster reporting
- Reduced waiting times
- Better chronic disease monitoring
However, successful implementation will depend heavily on:
- careful governance,
- good evidence,
- clinical oversight,
- public trust,
- and maintaining the human side of healthcare.
A Balanced Summary
AI in the NHS is already real, but still at an early stage of adoption.
Current use is best described as:
Promising applications in partial use, being introduced gradually and carefully while safety, effectiveness and governance continue to be evaluated.
The NHS is unlikely to move recklessly because healthcare carries high stakes. Instead, adoption will probably continue incrementally, with evidence and clinical confidence building over time.
If implemented wisely, AI has the potential to become one of the most important developments in modern healthcare — not by replacing clinicians, but by helping them deliver safer, faster and more personalised care.
Useful Resources and Further Reading
- NHS England: Artificial Intelligence and Machine Learning
- NHS AI Lab
- NHS AI Knowledge Repository
- NICE: Evidence Standards Framework for Digital Health Technologies
- UK Government: AI Opportunities Action Plan
- Royal College of Radiologists: Artificial Intelligence
- British Institute of Radiology: Artificial Intelligence Special Interest Group
- The Health Foundation: How Could AI Improve the NHS?
- The King’s Fund: Artificial Intelligence and the NHS
- Nature: Artificial Intelligence in Healthcare Collection
- The Lancet Digital Health
Using AI Safely When You Have Aspergillosis
Artificial intelligence (AI) tools (for example, ChatGPT and other “medical chatbots”) can help people living with aspergillosis understand information, prepare for appointments, and feel more confident asking questions.
Used well, AI can be like a helpful explainer.
Used badly, it can be misleading — especially for conditions like aspergillosis where treatment decisions are complex.
This page explains what is safe, what is not safe, and how to use AI in a way that supports (not replaces) your clinical team.
Who is this page for?
This guidance is for people affected by:
-
Chronic Pulmonary Aspergillosis (CPA)
-
Allergic Bronchopulmonary Aspergillosis (ABPA)
-
Severe Asthma with Fungal Sensitisation (SAFS)
-
Aspergillus bronchitis
-
Other long-term Aspergillus-related lung problems
A simple rule that keeps you safe
AI should improve your understanding — it should not change your treatment.
If an AI tool suggests starting, stopping, or changing medication, do not act on it without speaking to your clinician.
What AI is good for
AI tools are usually helpful for:
Explaining medical words in plain language
Examples:
-
“What is Aspergillus Immunoglobulin G (IgG)?”
-
“What does ‘eosinophils’ mean?”
-
“What is a CT scan finding such as ‘cavity’ or ‘bronchiectasis’?”
Understanding medicines (general information)
AI can explain:
-
What a medicine is for
-
How it works in the body
-
Common side effects (in general terms)
-
Why monitoring is needed
This can be helpful for antifungal medicines such as itraconazole, voriconazole, posaconazole, and isavuconazole.
Preparing for appointments
AI can help you create a list of questions, for example:
-
“What monitoring do I need while on antifungals?”
-
“What symptoms should prompt urgent review?”
-
“How do we judge whether treatment is working?”
Summarising research articles
If you paste a paragraph from a paper (or describe it), AI can often translate it into patient-friendly language.
(Always remember: AI can sometimes get details wrong — see below.)
Organising your story
Many people find it useful to ask AI to format:
-
A timeline of symptoms
-
A list of medicines and dates
-
A short “what I want from this appointment” summary
This can make consultations more productive.
What AI is NOT safe for
AI should not be used for:
Diagnosis
Aspergillosis diagnosis usually depends on a careful combination of:
-
Symptoms and clinical history
-
Imaging (often computed tomography, CT)
-
Blood tests
-
Sputum tests / microbiology
-
Sometimes bronchoscopy results
AI cannot reliably “diagnose” from symptoms or a single test result.
Treatment decisions
Do not use AI to decide:
-
Whether you should start or stop antifungals
-
Steroid doses or tapering plans
-
Whether you “should” try biologics (for example, omalizumab)
-
Whether a side effect is safe to ignore
These decisions must be individualised and clinician-led.
Urgent situations
If you have worsening breathlessness, fever, chest pain, or coughing blood (haemoptysis), seek medical advice urgently.
AI is not an emergency service.
Why aspergillosis needs extra caution
Aspergillosis care can be complicated because:
-
Some antifungal medicines have important drug interactions
-
Blood levels may need monitoring (therapeutic drug monitoring)
-
Side effects can overlap with symptoms of lung disease
-
Different Aspergillus-related conditions can look similar but need different management
AI tools can also:
-
Over-generalise from asthma guidance
-
Confuse chronic disease with invasive disease
-
“Hallucinate” (invent) facts, references, or confident-sounding explanations
-
Be out of date
Privacy and confidentiality: what not to share with AI
To protect your privacy, avoid typing in:
-
Your full name
-
Date of birth
-
NHS number
-
Home address
-
Phone number
-
Identifiable clinic letters or reports (unless anonymised)
A safer way to write questions
Instead of pasting an entire letter, use a summary like:
“Adult with chronic lung disease, on itraconazole 200 mg daily, recent CT shows cavities, asking about monitoring and side effects.”
That’s usually enough for education and planning questions.
A safe “4-step” way to use AI
-
Ask AI to explain (terms, tests, general concepts)
-
Ask AI to help you prepare questions
-
Discuss those questions with your clinician
-
Only change treatment after clinical advice
A quick safety checklist
Before trusting an AI answer, ask:
-
Is this general education, or is it telling me what I should do?
-
Does it recommend changing my medicine or dose?
-
Does it mention checking interactions or monitoring?
-
Does it conflict with my current plan?
-
Is this situation urgent?
If any answer worries you: pause and ask your care team.
Example prompts patients can use safely
You can copy/paste these into an AI tool:
-
“Explain Chronic Pulmonary Aspergillosis (CPA) in plain language.”
-
“What questions should I ask about long-term itraconazole treatment?”
-
“What monitoring is commonly recommended for antifungal medicines?”
-
“Can you help me write a one-page symptom and medication summary for my clinic appointment?”
-
“Here is a paragraph from a research paper — can you summarise it in patient-friendly language and list any uncertainties?”
Tip: If you want a more cautious response, add:
“Please be conservative and tell me what you’re unsure about.”
Signs an AI answer may be unreliable
Be cautious if the AI:
-
Sounds very confident but gives no clear reasoning
-
Gives exact doses or taper schedules
-
Claims “this is definitely ABPA/CPA” from limited information
-
Provides references you cannot find elsewhere
-
Dismisses side effects, interactions, or monitoring
-
Encourages you to delay medical care
Final reminder
AI can be a helpful tool for understanding and preparing — but it is not a substitute for a specialist team.
If you are unsure, or something feels wrong, it is always reasonable to contact your clinician, specialist nurse, or GP.
Medical disclaimer
This page is for general information only and is not medical advice. Always follow the guidance of your healthcare team, especially regarding diagnosis, medicines, and urgent symptoms.


